Asacol and Ulcerative colitis - a phase IV clinical study of FDA data

Summary:

Ulcerative colitis is found among people who take Asacol, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Asacol and have Ulcerative colitis. It is created by eHealthMe based on reports of 17,445 people who have side effects when taking Asacol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 28, 2023

17,445 people reported to have side effects when taking Asacol.
Among them, 1,499 people (8.59%) have Ulcerative colitis.

What is Asacol?

Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 18,163 Asacol users for its effectiveness, alternative drugs and more.

What is Ulcerative colitis?

Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine) is found to be associated with 2,423 drugs and 1,855 conditions by eHealthMe.

Number of Asacol and Ulcerative colitis reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Asacol and have Ulcerative colitis?

Check whether Ulcerative colitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .

Related studies

How severe was Ulcerative colitis and when was it recovered:

Ulcerative colitis in Asacol

Expand to all the drugs that have ingredients of mesalamine:

Ulcerative colitis and drugs with ingredients of mesalamine (4,824 reports)

Alternative drugs to, pros and cons of Asacol:

Asacol (18,163 reports)

Common Asacol side effects:

Browse all side effects of Asacol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ulcerative colitis treatments and more:

Ulcerative colitis (135,468 reports)

COVID vaccines that are related to Ulcerative colitis:

Common drugs associated with Ulcerative colitis:

All the drugs that are associated with Ulcerative colitis:

Ulcerative colitis (2,423 drugs)

Common conditions associated with Ulcerative colitis:

Acne: 5,987 reports
Crohn's disease: 1,226 reports
High blood pressure: 1,123 reports
Rheumatoid arthritis: 1,029 reports
Multiple sclerosis: 681 reports

All the conditions that are associated with Ulcerative colitis:

Ulcerative colitis (1,855 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mesalamine (the active ingredients of Asacol) and Asacol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.